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Abstract 
Background: Real-world environments comprise surfaces of different textures, densities and 
gradients, which can threaten postural stability and increase falls risk.  However, there has 
been limited research that has examined how walking on compliant surfaces influences gait 
and postural stability in older people and PD patients. 
 
Methods: PD patients (n = 49) and age-matched controls (n = 32) were assessed using three-
dimensional motion analysis during self-paced walking on both firm and foam walkways.  
Falls were recorded prospectively over 12 months using daily falls calendars. 
 
Results: Walking on a foam surface influenced the temporospatial characteristics for all 
groups, but PD fallers adopted very different joint kinematics compared with controls.  PD 
fallers also demonstrated reduced toe clearance and had increased mediolateral head motion 
(relative to walking velocity) compared with control participants. 
 
Conclusions: Postural control deficits in PD fallers may impair their capacity to attenuate 
surface-related perturbations and control head motion.  The risk of falling for PD patients 
may be increased on less stable surfaces. 
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Introduction 
Parkinson’s disease (PD) is characterised by postural instability and gait difficulties that 
significantly impact upon independence and quality of life[1, 2] and increase falls risk.  PD 
patients have a nine times greater risk of recurrent falls than similarly aged healthy 
individuals[3].  Recent prospective research has highlighted that nearly half of PD patients 
experienced at least one fall over a six-month[4] (48%) and twelve-month[5] (45%) period.  
A similar falls rate was reported over a three-month period in a meta-analysis of six 
prospective studies (46%)[6].  With nearly half of these falls occurring during dynamic tasks, 
such as walking and turning[7], further research is needed to better understand the 
mechanisms underpinning gait disability in this population when walking in environments 
representative of real-world settings. 
 
Parkinsonian gait is characterised by reduced walking velocity[8-11] and stride length[8-11] 
and less rhythmic acceleration profiles for the trunk[12] and head[13] compared with age-
matched controls.  PD patients who fell during a 12-month follow-up period had reduced 
stride length, arm swing, single support time and walking speed compared with controls and 
increased mediolateral head motion compared with PD non-fallers and controls following 
adjustment for walking speed[14].  A cross-sectional study[13] reported differences in 
walking velocity and stride timing variability between PD fallers and non-fallers, but the 
subsequent prospective study of these patients demonstrated only reduced cadence for PD 
fallers[5].  While these changes are widely recognised, many of these observations have been 
made while walking on firm and predictable surfaces.  Real-world walking environments, 
however, comprise surfaces of different textures, densities and gradients, which require 
constant adjustments to the body’s movement patterns to maintain stability.  Compliant 
surfaces, such as grass, sand or carpet may reveal differences in one’s capacity to use the 
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kinaesthetic system to accurately detect the position of the body relative to the surface[15] 
and adjust gait patterns.  To accommodate for walking on foam surfaces, healthy younger 
adults exhibit increased step length, step width, step time and toe clearance[16].  However, an 
accelerometry-based study reported no compensatory temporospatial adjustments for healthy 
older adults while walking on a foam-covered walkway[17].  Given that PD fallers have 
poorer segmental control during controlled walking tasks[14], their risk of falling could be 
exacerbated under conditions that challenge postural stability.  Therefore, a better understand 
of surface-related adaptations to gait and postural control is essential to facilitate the 
development of more effective screening tools and intervention strategies to reduce the 
incidence of falls in PD patients. 
 
We examined the gait adaptations made in response to walking on a foam surface by PD 
patients who prospectively reported falling over a twelve-month period.  We hypothesised 
that PD fallers would show different adaptations in both temporospatial and joint kinematic 
characteristics compared to PD non-fallers and age-matched controls (fallers and non-fallers) 
and would have poorer control of the body’s segments during walking. 
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Methodology 
Study Population 
Patients diagnosed with idiopathic PD based on the UK Brain Bank Criteria (n = 49) were 
recruited from neurology clinics and community support groups in South-East Queensland 
between March 2005 and December 2006.  All patients were confirmed to have PD by their 
treating neurologist. Concurrently, age-matched controls (n = 32) were randomly recruited 
from the Brisbane metropolitan area via the Australian electoral role (Table 1).  This sample 
was consistent with the population described previously[14], with the exception of two 
control participants whose data could not be included due to problems with data collection on 
the foam surface.  Participants were sent a letter of invitation, before being contacted by 
telephone to establish their interest in participating.  Participants were excluded if they were 
unable to ambulate independently, had a recent or recurrent history of musculoskeletal injury 
or surgery, or had significant visual (Bailey-Lovie high contrast visual acuity >0.30 logMAR) 
or cognitive impairment (Mini Mental State Exam[18] score <24).  All participants gave 
written informed consent in accordance with the Declaration of Helsinki and the experimental 
protocol was approved by the Queensland University of Technology Human Research Ethics 
Committee.  Based on studies of walking in PD[1, 9, 14], a minimum of 15 participants per 
group was considered to be sufficient to detect differences between groups. 
 
Insert Table 1 about here. 
 
Clinical Assessment 
Disease severity was established using the Unified Parkinson’s Disease Rating Scale[19] 
(UPDRS) and the Hoehn & Yahr (H&Y) score[20] (Table 1).  A measure of postural 
instability and gait disability (PIGD) was derived from the UPDRS (sum of items 13-15, 27-
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30).  Freezing of gait and fear of falling were assessed using the Freezing of Gait (FOG)[21] 
questionnaire and the Modified Falls Efficacy Scale[22], respectively.  All procedures were 
undertaken within 1 to 2 hours of medication to ensure that patients were optimally-
medicated. 
 
Three-Dimensional Gait Assessment 
Gait was assessed during six trials while; i) walking barefooted at a self-selected pace along a 
firm walkway (L: 12 m x W: 2.2 m x H: 0.1 m) and ii) walking along the same walkway 
covered with a layer of foam (10cm thick; 0.032g/cm3 density).  Twenty-eight markers were 
positioned in accordance with the Helen Hayes marker set[23], modified to include the upper 
body and head.  Markers were attached on the trunk (sacrum, sternum, C7 spinous process), 
arms (lateral border of the acromion, olecranon process of the humerus, radial and ulnar 
styloids), and head (supra-auricular point, top of the head).  The same experienced movement 
specialist attached the markers and labelled and analysed the data to minimise errors 
associated with inter-rater reliability.  
 
Markers were tracked within the central 4 m length of the 12 m walkway (50 Hz) by a 
previously calibrated six-camera motion analysis system (Motus 2000; Vicon, Oxford, UK) 
for two complete gait cycles (1 right; 1 left).  Data were reconstructed using direct linear 
transformation (DLT)[24] and temporospatial and angular quantities for the lower limbs were 
derived.  These included stride length, stride frequency (cadence), step width, double support 
(percent of time with both feet on the ground), stride timing variability (SD of stride 
period)[25], walking velocity and the Gait Stability Ratio (GSR; cadence/walking 
velocity)[26].  Peak toe clearance was defined as the maximum vertical displacement of the 
toe relative to the top of the firm and foam surfaces during the swing phase.  The ML and 
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vertical (VT) displacement of the head and pelvis were assessed to provide a measure of 
segmental control.  Arm swing was calculated as displacement of the wrists in the sagittal 
plane. 
 
Sagittal plane angular kinematics of the trunk, hip, knee and ankle joints were examined.  
Trunk flexion was the angle between the vector joining the sacral and C7 markers and the 
vertical axis of the global coordinate system.  Hip flexion/extension was the angle between 
the vertical axis of the pelvis segment and the vector joining the hip and knee joints.  Knee 
flexion/extension was the angle between the vectors joining the hip and knee joints and the 
knee and ankle joints.  Ankle plantar- and dorsi-flexion was the angle between the vectors 
joining the knee, ankle and second metatarsal joints, where zero degrees represented the point 
at which the two vectors were perpendicular.  These variables are altered in PD patients[9-11] 
and PD patients who fall[14] while walking on firm and non-threatening surfaces. 
 
12-Month Prospective Follow-up. 
Participants recorded any falls or injuries on a daily falls calendar, which they returned on a 
monthly basis via a reply-paid envelope over the subsequent 12-month period.  Participants 
provided details on the timing, location and cause of any fall and any injuries.  If a participant 
failed to return their monthly calendar, they were sent a reminder by mail and contacted via 
telephone.  A fall was defined as “an unintentional coming to the ground or some lower level 
not as a result of a major intrinsic event (e.g. stroke) or overwhelming hazard”[27]. 
 
Statistical Analysis. 
Analysis of variance (ANOVA) with one repeated measure (surface, 2 levels) was used to 
determine mean differences between; 1) PD patients and controls; and 2) fallers or non-fallers 
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for the temporospatial, segmental motion and joint kinematic variables.  Tukey’s Honestly 
Significant Difference (HSD) post-hoc test was used to determine statistically significant 
differences between faller and non-faller groups; this controls for the overall significance 
level when performing all pairwise comparisons in ANOVA and reduces the likelihood of a 
Type 1 error.  Continuous demographic variables were examined using a one-way ANOVA, 
while the degree of association between the categorical variables was assessed with the chi-
square (χ2) test.  All statistical procedures were conducted using SPSS 16 and the level of 
significance was set at p < 0.05.
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Results 
Falls 
Thirty-two PD patients (65%) and 17 control participants (53%) reported falling at least once 
during the 12-month follow-up, while 21 (43%) PD and 9 (28%) control participants reported 
falling twice or more.  Participants were divided into four groups, based on the prospective 
falls data; PD Fallers (n = 32); PD Non-Fallers (n = 17); Control Fallers (n = 17); and Control 
Non-Fallers (n = 15). 
 
Clinical Characteristics 
PD fallers had significantly longer disease duration and higher FOG scores than PD non-
fallers, had an increased fear of falling compared to PD non-fallers and controls and reported 
more falls during the previous 12 months than PD and control non-fallers.  PD fallers and 
non-fallers had similar average daily Levodopa intake and disease severity and neither group 
demonstrated freezing of gait during walking (Table 1). 
 
Temporospatial Characteristics 
 
Insert Figure 1 about here. 
 
For all participants, walking on the foam surface significantly increased stride length, step 
width, walking velocity and toe clearance, while cadence, double support and GSR were all 
significantly reduced.  PD fallers took shorter strides, walked more slowly, spent more time 
in double support, had increased stride timing variability and poorer GSRs than the control 
fallers and non-fallers on both surfaces (Figure 1).  PD fallers had significantly reduced toe 
clearance compared with the control groups and a significant surface*group interaction 
(F(3,77) = 3.704, p = 0.015) demonstrated that, while the control fallers and non-fallers 
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significantly increased toe clearance on the foam surface, both PD groups showed no 
significant change (Figure 1). 
 
Segmental Motion 
While traversing the foam surface, all groups had increased VT and ML head and pelvis 
motion. PD fallers had significantly more ML head motion than PD non-fallers and controls 
following adjustment for walking velocity (Figure 2).  Arm swing was significantly reduced 
for PD patients compared to controls, even following normalisation for walking velocity. 
 
Insert Table 2 and Figure 2 about here. 
 
Trunk Flexion 
A significant surface*group interaction (F(3,77) = 3.078, p = 0.032) for trunk flexion 
demonstrated that, while PD fallers and non-fallers and control fallers all increased trunk 
flexion on the foam surface, control non-fallers did not.  However, following normalisation to 
walking velocity, PD fallers had significantly greater trunk flexion relative to control fallers 
and non-fallers on both surfaces (Figure 2).  
 
Joint Kinematics: Range of Motion 
PD fallers had reduced hip and knee flexion/extension ranges compared to control groups, but 
following adjustment for walking velocity, only the reduced knee range of motion remained 
significant (Table 2).  Similarly, a surface*group interaction for normalised hip 
(F(3,77) = 4.348, p = 0.007) and knee flexion/extension range (F(3,77) = 2.838, p = 0.043) 
demonstrated that, while all groups increased their hip and knee range of motion on the foam 
surface, these changes were greater for PD fallers (Figure 3).   
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Insert Figure 3 about here. 
 
Joint Kinematics: Stance Limb 
At peak toe-clearance, PD fallers had increased knee flexion in the stance limb compared 
with control fallers and non-fallers.  Additionally, significant surface*group interactions were 
observed for normalised (for walking velocity) hip (F(3,77) = 2.674, p = 0.050) and knee 
(F(3,77) = 3.191, p = 0.028) flexion/extension angles for the stance leg at peak toe clearance 
of the contra-lateral limb (Figure 4).  These relationships demonstrated that control 
participants had significantly reduced knee flexion (i.e. straighter knee) in the stance limb at 
peak toe clearance on the foam surface (Table 2).  In contrast, PD patients maintained a 
similar degree of knee flexion on the firm and foam surfaces, but had reduced hip extension 
(i.e. straighter hip) on the foam surface. 
 
Insert Figure 4 about here. 
 
Joint Kinematics: Swing Limb 
Similar to the stance limb, PD fallers had increased knee flexion angle in the swing limb 
compared with control fallers and non-fallers.  Significant surface*group interactions for 
normalised knee flexion/extension (F(3,77) = 4.928, p = 0.003) and ankle plantar/dorsiflexion 
(F(3,77) = 3.018, p = 0.035) at peak toe clearance (Figure 4) illustrated that, while control 
participants maintained a consistent knee flexion angle at peak toe clearance on both surfaces, 
PD patients significantly increased knee flexion and ankle plantar-flexion on the foam 
surface.
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Discussion 
This study is the first to examine surface-related adaptations of gait and segmental control in 
PD patients who prospectively reported falling.  PD fallers had different walking patterns to 
age-matched controls and adapted differently to walking on a foam surface. There were 
marked differences in the patterns of lower limb kinematics which resulted in reduced 
amplitudes of toe clearance during stepping.  PD fallers also demonstrated increased disease 
duration and freezing of gait compared with PD non-fallers and a greater fear of falling 
compared with PD non-fallers and controls.  Fear of falling has been associated with poorer 
gait performance[28] and, while it may have emanated from the greater number of previous 
falls experienced by these participants, it could also reflect a greater awareness of deficits in 
walking stability. 
 
In agreement with previous research, there were clear differences in temporospatial gait 
parameters for PD patients with respect to age-matched controls[1, 9-11] and for PD fallers 
relative to non-fallers and controls[14] on both firm and foam surfaces. PD fallers 
demonstrated increased stride timing variability compared with controls and while this was in 
agreement with two cross-sectional studies, it was in contrast to two prospective studies[5, 
14].  However, unlike previous research, the current study examined gait on a compliant 
walking surface, which may have exposed motor control deficits and accentuated stride 
timing variability in PD fallers.    
 
When walking on the foam surface all groups increased stride length, step width and walking 
speed.  This was commensurate with findings for younger participants walking on a foam 
surface[16], but not those for older adults[17].  These changes may represent two types of 
strategic adaptation to the foam surface. Firstly, increases in stride length and walking 
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velocity reduce the number of times that each foot contacts the challenging surface[29] 
thereby limiting the number of opportunities for the body to be destabilised. While plausible, 
this explanation is unlikely to apply to real-world situations where compliant surfaces can 
extend over larger areas. An alternate explanation could be that the increased step width and 
stride length increased the base of support thereby providing greater stability for controlling 
the body throughout the gait cycle[16].   
 
Although all groups demonstrated similar changes in stride length, step width and walking 
velocity on the foam surface, PD fallers recorded reduced toe clearance on the firm surface 
and unlike the age-matched controls (fallers and non-fallers), did not increase toe clearance 
on the softer surface.  
 
Alterations in body and limb control provide insight into the origin of these differences. PD 
fallers walked with increased trunk flexion (relative to walking velocity), which, without any 
other compensation, would position the COM further ahead of the base of support and 
challenge postural stability. However, PD fallers increased knee flexion in the stance limb, 
which should lower the COM and shift it posteriorly; this would distribute the mass over the 
base of support and improve the stability of the body[16]. The lower COM position that 
resulted from having a more flexed knee during stance required PD fallers to increase knee 
flexion in the swing leg at peak toe clearance to ensure that they adequately cleared the 
walking surface.  However, PD patients had increased ankle plantar-flexion during the swing 
phase which effectively positioned the toe closer to the floor.  In contrast, the age-matched 
controls compensated by lifting their feet higher while walking on the compliant terrain, 
which limits the risk of tripping[16].  PD fallers may, therefore, be at a higher risk of tripping 
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compared with age-matched controls, particularly on compliant or uneven surfaces, where the 
height of the walking surface is constantly changing. 
 
PD fallers demonstrated increased normalised ML head motion compared with PD non-
fallers and control groups and, while not statistically significant (surface*group interaction; 
p = 0.098), there was evidence that this was exacerbated on the foam surface.  This may be 
indicative of a postural control deficit in PD fallers, which impaired their capacity to 
attenuate surface-related perturbations and control head motion.  Increased head motion may 
impair the ability to use visual and vestibular cues to regulate upright posture during 
walking[30]. 
 
These findings should be considered in light of several delimitations.  Firstly, although 
similar to previous studies[1, 9, 14], a larger sample may provide further insight into surface-
related gait adaptations of PD patients.  Secondly, the PD patients assessed for this research 
were largely early stage patients (H&Y≤ 2) and falls are a significant problem even in this 
early stage[4].  These postural control impairments may be exacerbated in later stage PD 
patients who have an increased risk of falling.  Finally, while it is unlikely that an individual 
will be required to walk continuously on a foam surface in the real-world setting, it provides 
an easily controlled experimental surface that is analogous with real-world surfaces, such as 
grass, sand and carpet.  
 
PD patients demonstrate different adaptive strategies while walking on less stable surfaces 
and, combined with poorer head control, likely expose these individuals to a greater risk of 
falling.  These findings highlight the importance of examining gait and dynamic postural 
control under situations that are more applicable to the real-world setting.  Future research 
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should examine the predictive power of gait-related measures with the aim of developing 
better screening tools and interventions to identify and assist patients with a higher propensity 
for falling. 
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Figure Captions 
Figure 1: Mean (+1 SEM) stride length, walking velocity, toe clearance, double-support time, 
stride timing variability and gait stability ratio for the four groups on the firm and foam 
surfaces.  N.B. † denotes a significant surface*group interaction (p<0.05). 
 
Figure 2: Mean (+1 SEM) values for a) normalised trunk flexion angle and normalised 
mediolateral displacement of the; b) head and; c) pelvis for the PD and control fallers and 
non-fallers on the firm and foam surfaces. 
 
Figure 3: Average (+1 SEM) normalised sagittal joint range of motion for the hip, knee and 
ankle joints for the four groups walking on the firm and foam surfaces.  N.B. † denotes a 
significant surface*group interaction (p<0.05). 
 
Figure 4: Average (+1 SEM) normalised hip, knee and ankle joint angles at peak toe 
clearance for the stance limb (Figures 3a to 3c) and swing (Figures 3d to 3f) limbs for the 
four groups walking on the firm and foam surfaces. N.B. † denotes a significant 
surface*group interaction (p<0.05) and negative joint angles represent hip and knee extension 
or ankle plantar-flexion. 




 
Table 1: Demographics and disease-specific scores for the Parkinson’s disease and Control participants and the faller and non-faller sub-
groups. Data represent the mean (and standard error of the mean (SEM)) values or absolute numbers and percentages. 
 
 
 Parkinson’s Disease  Controls   
 All PD PD Faller PD Non-Faller  All Controls Control Faller Control Non-Faller   
 (n = 49) (n = 32) (n = 17)  (n = 32) (n = 17) (n = 15)   
           Mean (SEM) Mean (SEM) Mean (SEM)  Mean (SEM) Mean (SEM) Mean (SEM)  Sig. 
Demographics          
Age (years) 66.4 (1.2) 
 
66.2 (1.4) 66.9 (2.1)  68.4 (1.5) 
 
70.2 (2.3) 66.3 (1.6)  ns 
Gender (male) 33 (67.3%) 20 (62.5%) 13 (76.5%)  19 (59.4%) 10 (58.8%) 9 (60.0%)  ns 
Height (cm) 167.1 (1.1) 167.3 (1.4) 166.6 (1.7)  168.9 (1.5) 167.5 (2) 170.4 (2.3)  ns 
Mass (kg) 73.8 (1.9) 76.1 (2.5) 69.4 (2.8)  78.5 (2.9) 76.0 (4.0) 81.4 (4.1)  ns 
BMI (kg/m2) 26.4 (0.6) 27.1 (0.8) 24.9 (0.8)  27.4 (0.7) 26.9 (1.1) 27.9 (0.9)  ns 
          Falls History and Fear of Falls          
Modified Falls Efficacy Scale 8.7 (0.3) 8.3 (0.4) 9.7 (0.1)  9.7 (0.1) 9.7 (0.2) 9.7 (0.2)  a, b, c, d 
Previous Falls 2.9 (2.0) 4.3 (3.1) 0.3 (0.1)  0.3 (0.1) 0.5 (0.2) 0.1 (0.1)  a, b, d  
          Visual and Cognitive Functioning          
High Contrast Visual Acuity (LogMAR) 
 
0.00 (0.01) 0.01 (0.02) -0.02 (0.02)  0.00 (0.01) 0.02 (0.02) -0.01 (0.01)  ns 
Mini-Mental State Exam 27.4 (0.3) 27.1 (0.4) 27.8 (0.5)  27.9 (0.4) 27.7 (0.6) 28.1 (0.6)  ns 
          Neurological Exam          
Disease Duration (years) 5.4 (0.5) 6.2 (0.7) 3.9 (0.6)      b 
Levodopa dose (mg/day) 657.6 (75.7) 688.8 (109.2) 598.8 (75.8)      ns 
Freezing of Gait 4.0 (0.6) 4.2 (0.7) 2.1 (0.6)      b 
Hoehn & Yahr 1.8 (0.1) 1.8 (0.1) 1.6 (0.2)      ns 
UPDRS Total 31.8 (2.3) 34.5 (2.7) 26.6 (3.7)      ns 
PIGD 3.9 (0.5) 4.4 (0.6) 3.0 (0.6)      ns 
                     ns. No significant differences between the groups (p > 0.05) 
a. PD significantly different to Controls (p < 0.05) 
b. PD Fallers significantly different to PD Non-Fallers (p < 0.05) 
c. PD Fallers significantly different to Control Fallers (p < 0.05) 
d. PD Fallers significantly different to Control Non-Fallers (p < 0.05) 
  
Table 2: Segmental coordination and sagittal joint kinematics for the Parkinson’s disease and Control fallers and non-fallers while walking 
on the firm and foam surfaces. Data represent the mean (and standard error of the mean (SEM)) values. 
 
 Firm Surface  Foam Surface  
 PD Faller PD Non-Faller Control Faller Control Non-Faller  PD Faller PD Non-Faller Control Faller Control Non-Faller  
 (n = 32) (n = 17) (n = 17) (n = 15)  (n = 32) (n = 17) (n = 17) (n = 15)  
            Mean (SEM) Mean (SEM) Mean (SEM) Mean (SEM)  Mean (SEM) Mean (SEM) Mean (SEM) Mean (SEM) Sig. 
Segmental Motion (cm)           
Avg Arm Swing 21.55 (2.33) 25.39 (2.16) 28.54 (1.66) 33.10 (3.17)  23.12 (2.64) 24.54 (2.29) 28.86 (1.75) 36.42 (3.73) a, d 
Norm Arm Swing 20.22 (1.66) 21.94 (1.71) 23.81 (1.54) 27.51 (2.39)  21.61 (2.03) 20.78 (1.76) 23.22 (1.47) 27.80 (2.18) a 
           Norm Head Motion - VT 2.86 (0.12) 2.80 (0.11) 2.85 (0.12) 2.88 (0.22)  3.13 (0.13) 3.21 (0.17) 3.31 (0.18) 3.25 (0.25) § 
Norm Head Motion - ML 5.43 (0.35) 4.01 (0.27) 4.13 (0.34) 4.43 (0.44)  6.21 (0.44) 4.30 (0.29) 4.51 (0.43) 4.37 (0.45) §, a, b, c, d 
Norm Pelvis Motion - VT 2.87 (0.11) 2.81 (0.10) 2.82 (0.12) 2.82 (0.21)  3.35 (0.11) 3.34 (0.14) 3.42 (0.18) 3.37 (0.24) § 
Norm Pelvis Motion - ML 4.44 (0.26) 3.65 (0.22) 3.67 (0.21) 3.92 (0.23)  5.05 (0.32) 4.46 (0.37) 4.01 (0.35) 4.29 (0.32) §, a 
           Joint  Kinematics (°)           
Trunk Flexion Angle  13.55 (0.81) 11.56 (0.83) 10.77 (0.61) 11.73 (0.79)  14.60 (0.86) 12.85 (0.90) 11.95 (0.63) 12.08 (0.87) †, §, a 
Norm Trunk Flexion Angle 14.21 (1.27) 10.31 (0.83) 9.08 (0.70) 9.74 (0.76)  15.26 (1.39) 11.22 (0.85) 9.69 (0.66) 9.61 (0.84) §, a, c, d 
           Norm Hip Flx/Ext Range 33.57 (0.53) 33.59 (0.83) 33.57 (0.69) 33.62 (0.56)  37.47 (0.61) 36.67 (0.97) 35.77 (0.76) 35.82 (0.48) †, § 
Norm Knee Flx/Ext Range 45.64 (1.17) 44.53 (1.20) 42.61 (0.96) 42.00 (1.00)  52.21 (1.29) 49.07 (1.21) 47.40 (1.07) 47.23 (1.13) †, §, a, c, d 
Norm Ankle Dor/Pln Range 23.35 (0.81) 23.67 (1.15) 21.66 (0.83) 22.23 (1.13)  22.17 (0.73) 22.52 (0.98) 21.77 (0.96) 20.67 (0.86) § 
           Joint Kinematics at Peak Toe Clearance - Stance Leg (°)        
Norm Hip Flx/Ext Angle -12.01 (1.86) -13.38 (1.66) -13.10 (1.83) -12.00 (1.50)  -9.78 (1.94) -11.68 (1.34) -13.40 (1.73) -11.82 (1.77) †, § 
Norm Knee Flx/Ext Angle 8.07 (1.47) 7.60 (1.04) 4.44 (1.14) 3.80 (1.16)  8.34 (1.56) 7.45 (1.20) 3.62 (1.15) 2.48 (1.21) †, §, a, c, d 
Norm Ankle Dor/Pln Angle 0.61 (0.37) 1.41 (0.43) -0.69 (0.45) 0.35 (0.38)  2.37 (0.78) 3.64 (0.94) 2.27 (0.82) 1.44 (0.74) § 
           Joint Kinematics at Peak Toe Clearance - Swing Leg (°)        
Norm Hip Flx/Ext Angle 18.85 (1.52) 15.82 (1.60) 16.67 (1.92) 19.28 (1.31)  22.27 (1.78) 19.29 (1.54) 19.89 (1.83) 22.21 (1.53) § 
Norm Knee Flx/Ext Angle 11.04 (1.62) 10.00 (2.07) 7.52 (1.66) 7.25 (1.04)  22.00 (3.80) 16.11 (3.24) 8.69 (1.45) 7.64 (1.20) §, a, c, d 
Norm Ankle Dor/Pln Angle 1.32 (0.59) 1.10 (0.81) -0.65 (0.52) 1.18 (0.85)  -5.82 (1.01) -3.71 (1.13) -2.82 (1.00) -3.09 (0.59) †, § 
                      ns. No significant differences between the groups (p > 0.05) 
† Significant Surface*Group interaction (p < 0.05) 
§. Firm surface significantly different to foam surface (p < 0.05) 
a. PD significantly different to Controls (p < 0.05) 
b. PD Fallers significantly different to PD Non-Fallers (p < 0.05) 
c. PD Fallers significantly different to Control Fallers (p < 0.05) 
d. PD Fallers significantly different to Control Non-Fallers (p < 0.05) 
   
